OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.01 Cr | ₹-0.05 Cr | ₹-0.29 Cr | ₹0.33 Cr | ₹0.10 Cr |
What is the latest Net Cash Inflow / Outflow ratio of OXYGENTA PHARMACEUTICAL ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.01 Cr |
Mar2023 | ₹-0.05 Cr |
Mar2022 | ₹-0.29 Cr |
Mar2021 | ₹0.33 Cr |
Mar2020 | ₹0.10 Cr |
How is Net Cash Inflow / Outflow of OXYGENTA PHARMACEUTICAL Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.01 Cr | Negative | |
Mar2023 | ₹-0.05 Cr | Negative | |
Mar2022 | ₹-0.29 Cr | Negative | |
Mar2021 | ₹0.33 Cr | 227.00 | |
Mar2020 | ₹0.10 Cr | - |
Compare Net Cash Inflow / Outflow of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹298.0 Cr | -7.5% | -26.1% | 125.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -7.5% |
-26.1% |
125.2% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses